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Abstract 
Salivary glands (SG) are essential for the maintenance of oral health by providing lubrication 
and antimicrobial protection to the mucosal and tooth surfaces. Saliva is modified and delivered to the 
oral cavity by a complex multifunctional ductal system. During development these ducts form as solid 
tubes, which undergo cavitation to create lumens. Apoptosis has been suggested to play a role in this 
cavitation process along with changes in cell polarity. Here we show that apoptosis occurs from the 
very earliest stages of mouse SG development, much earlier than previously reported. Apoptotic cells 
were observed in the centre of the first epithelial stalk at early stage E12.5 using both TUNEL staining 
and Cleaved Caspase-3 immunofluorescence. The presumptive lumen space was highlighted by the co-
localisation of a predictive lumen marker, Cytokeratin 7 (K7). At E14.5, as lumens start to form 
throughout the glands, apoptotic expression decreased while K7 remained positive. In vitro inhibition of 
all caspases in E12.5 and E13.5 SG resulted in wider ducts compared to the controls and a defect in 
lumen formation. In contrast no such defect in lumen formation was observed at E14.5. Our data 
indicates that apoptosis is involved during early stages of gland formation (E12.5 onwards) and appears 
important for shaping the forming ducts. 
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Introduction 
 During epithelial organogenesis, lumen formation within an initially solid tube is essential for 
building functional networks of epithelial tubes in different organs such as mammary and salivary 
glands (SG) (Kwon and Larsen 2015; Mailleux et al. 2007). It has been postulated that canalisation of 
SG ducts and other glands is due to clearance of the inner cell population within newly branched 
epithelial stalks due to apoptosis, programmed cell death. Lumen formation therefore occurs 
secondarily to branching morphogenesis (Andrew and Ewald 2010; Lubarsky and Krasnow 2003). The 
role of cell death in SGs, however, has recently been challenged with lumen formation occurring after 
apoptosis is blocked (Nedvetsky et al. 2014). 
As previously described SG development is generally classified into prebud, initial bud, 
pseudoglandular, canalicular and terminal bud stages, with gland initiation occurring around embryonic 
day E11 in the mouse (Jaskoll & Melnick 1999). The prebud stage is characterized as a thickening of 
the oral epithelium, which proliferates towards the underlying mesenchyme and forms an epithelial bud 
with a narrow stalk region (initial bud stage). The bud then undergoes clefting to create multiple buds 
that characterize the pseudoglandular stage. The epithelial stalks then undergo canalisation, whilst 
ductal and acinar cells then differentiate to achieve a mature gland (Jaskoll and Melnick 1999). This 
pattern of development is very similar to the stages observed during human development (Teshima et al. 
2011; Lourenço et al. 2008). 
To date, lumen formation in SGs has been reported to start from (Jaskoll et al. 2001; Tucker 
2007). Apoptotic cells have been observed localised in the developing ducts and active caspase 3, a 
central mediator of the apoptotic pathway, is expressed in these regions (Jaskoll and Melnick 1999; 
Jaskoll et al. 2001). In keeping with an active role of apoptosis in lumen formation, Survivin, a member 
of the inhibitors of apoptosis protein family (IAP) is expressed in the nucleus of epithelial cells 
bordering the forming lumina as the canals start to form (Jaskoll et al. 2001).  
 Programmed cell death can be triggered by different molecular pathways. The extrinsic 
pathway involves apoptotic signalling from outside the cell, mediated by members of the tumor necrosis 
factor receptor superfamily (Elmore 2007). The intrinsic pathway depends on endogenous factors to 
activate apoptosis and is stimulated by intracellular stress such as DNA damage, hypoxia, oncogene 
activation and deprivation of growth factors. The mitochondria is the central organelle of this pathway 
and releases several pro-apoptotic molecules into the cytoplasm (Elmore 2007; Taylor et al. 2008).  
Given the specific functions of the SG ductal system to properly secrete and deliver saliva in the 
oral cavity, it is important to understand the mechanisms involved in SG formation. In other systems 
cell polarisation, apoptosis, anoikis and cord hollowing have been suggested to play a role in epithelial 
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tubulogenesis (Nedvetsky et al. 2014; Mailleux et al. 2007; Debnath et al. 2002; Andrew and Ewald 
2010). Here we have concentrated on the role of apoptosis, analysing the temporal expression of 
apoptotic markers during early SG development, and using inhibition of apoptosis in culture, 
introducing a potential early role of caspase-dependent apoptosis in lumen formation starting prior to 
branching morphogenesis. 
 
Material and Methods 
 Organ culture: Mouse tissue was collected from wild type (WT) CD1 animals housed in the 
Biological Services Unit in New Hunts House at King’s College London, in approved non-SPF 
conditions. Mice were culled using schedule one culling methods, as approved by the Home Office and 
King´s College London. Animal experiments conform to ARRIVE Guidelines. Embryonic SGs at 
stages E12.5 to E14.5 were dissected out for cultures and immunohistochemistry analysis (N=6 of each 
stage and group).  
Pan-caspase inhibitor Z-VAD-FMK (G7231, Promega) was used for in vitro apoptotic 
inhibition at a range of concentrations (100, 150, 200µM) at E13.5 and E14.5 (N = 9) and at 100µM at 
E12.5 (N=18). Samples were placed on permeable membranes (BD) over culture medium (Advanced 
Dulbecco Modified Eagle Medium F12, Invitrogen; 1% GlutamaxTM, Invitrogen; 1% penicillin-
streptomycin) at 37°C and 5% CO2. Controls were cultured in DMSO at the same concentration. In situ 
CaspACE FITC-Z-VAD-FMK marker (G7461, Promega) was added to the culture medium in the last 
day for 3h. Cultured SGs were then fixed for 30min at room temperature (RT) and washed in PBS.  
Lysotracker RED (DND-99, Invitrogen) was added in culture medium (5µM) of live SGs (N=6 
of each stage) for 3h. After washing with fresh culture medium and PBT, samples were fixed in 4% 
paraformaldehyde for 30min at RT. Samples were permeabilised with PBT for 15min, followed by 
incubation in BS for 2h and DAPI (1:1000, Invitrogen) for 4h at RT. For 
immunohistochemistry/immunofluorescence and morphometric analysis see supplementary methods. 
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Results  
Previous papers have concentrated on apoptosis during duct cavitation from E14.5 onwards, we 
therefore wanted to analyse whether apoptosis also had a role during earlier stages of gland 
development, when the main stalk of the gland is formed. Morphological analysis of early stages is 
shown in Fig. 1 (A, E, I), and the epithelial structures of forming SGs are highlighted with E-cadherin 
staining (Fig. 1B, F, J). The opening of the first lumenal space appears from E13.5 (Fig. 1E, arrow). 
Specific apoptotic activity was confirmed using cleaved Caspase-3 and TUNEL at the same stages (Fig. 
1C,G,K and 1D,H,L respectively; Suppl. Fig.1). Both markers were found in the centre of the main 
epithelial stalk at E12.5 where the lumen space is due to form (Fig. 1C,D). High levels of apoptotic cells 
were observed at E13.5 within the main duct and the oral epithelium (Fig. 1G, H) (Suppl. Fig. 1). 
Interestingly, sparse (Fig. 1K, arrow) or no positive cells (Fig. 1L, arrowheads) were observed in the 
more developed ducts at E14.5. At E12.5, subtle luminal gaps were observed within the main stalk (Fig. 
1M, arrowheads), and at E13.5 they were clear within the duct associated with dying cells (Fig. 1O, 
arrowheads). In contrast the duct nearer the branching region had no yet initiated lumen formation. At 
these early stages, dying cells were found in the centre of the main epithelial stalk using Lysotracker 
staining, which labels lysozymes (Fig. 1N, P, arrows) (Fogel et al. 2012). Co-localisation of Lysotracker 
and cleaved caspase-3 expression was observed in the duct of the submandibular gland at E13.5 (Fig. 
1Q to T). In the sublingual gland, which is delayed in development compared to the neighbouring 
submandibular (Redman and Ball 1978), cleaved caspase-3 positive cells were observed running along 
the forming duct, while Lysotracker was not yet expressed (Fig.1R), confirming that presence of 
cleaved caspase-3 is an early indicator of lumenal space opening.  
 In order to confirm the presence of the forming lumen, Cytokeratin 7 (K7) was used to identify 
the presumptive luminal areas within the ducts as previously reported in developing SGs (Walker et al. 
2008), and also in less differentiated cells of the ductal tree in the mammalian pancreas (Bowens 1998) 
(Fig. 2). At E12.5, K7 expression was observed in the central cells of the epithelial stalk connected to 
the single bud (Fig. 2A, arrows), while expression was completely absent in the bud itself (Fig. 2A, 
arrowhead). At E13.5, a stronger expression was observed in the luminal cells of the main duct, lining 
the developing gaps (Fig. 2B, arrow). Towards the canalisation stage at E14.5, the expression of K7 
remained positive in the centre of the ductal structures where clear lumens were developing (Fig. 2C, 
arrows). During these stages K7 expression was also observed in the oral epithelium (OE), with 
expression increasing at later stage (E14.5) (Fig. 2D, arrow).  
The role of apoptosis in the main stalk was analysed by in vitro culture to block apoptosis using 
a pan-caspase inhibitor at 100µM in the developing glands. Caspases are the main effectors and 
activators of both the intrinsic and extrinsic apoptotic pathways (Degterev et al. 2003; Taylor et al. 
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2008). SG explants at E12.5 were cultured for 72 hours. During this period the WT cultures developed 
from a bud-like thickening to a main bud that had started to cleft, attached to the oral epithelium by a 
narrow stalk. In contrast the stalk region failed to narrow in the caspase treated explants (Fig. 3A, 
arrows). The diameter of the main primary stalk of each gland was measured in both experimental and 
control groups at the start and during culture, resulting in statistically significant difference from 24h 
(Fig. 3B),(p<0.05)(N=18). E12.5 cultures developed much slower than those without DMSO, the carrier 
used, indicating that this early stage is sensitive to even fairly low levels of this vehicle. In agreement 
with this higher concentration of inhibitor, and therefore carrier, led to arrest of gland development 
(data not shown).  We therefore performed a similar functional experiment using E13.5 and E14.5 SGs 
to assess the effects of pan-caspase inhibition on duct development at later stages. For this we used the 
concentrations of 100µM plus 150µM and 200µM. At E13.5 the addition of 150µM and 200µM 
inhibitor led to complete loss of apoptotic cells, as determined by activated caspase-3 staining, after 20 
hours in culture, while at 100µM a few positive cells were observed indicating some cells had escaped 
inhibition at this concentration at this stage (Fig. 4A, arrows) (N = 3 each concentration). At E13.5 
addition of Z-VAD-FMK inhibitor resulted in impaired stalk narrowing in a dose-dependent manner 
(Fig. 4B). At 150 µM a statistically significant failure in narrowing was observed after 72 hours in 
culture (Fig. 4C). The wide morphology of the ductal structures after treatment agrees with the data 
from E12.5, and suggesting that caspase-dependent apoptosis plays a role in the narrowing of the ducts 
prior to lumen formation. At E13.5, branching was also impaired showing reduction in the number of 
buds when cultured at higher concentrations of inhibitor (Fig. 4D, Fig. 5A-F). In contrast, E14.5 SG 
cultures showed no abnormality within all groups (Suppl. Fig. 2), agreeing with the fact that only low 
levels of apoptosis are evident at this stage (see Fig.1).  
In order to label cells that had been blocked by the inhibitor, plus cells that were undergoing 
cell death just before fixation, the apoptotic inhibitor marker FITC Z-VAD-FMK was added to E13.5 
cultures at 72hours (N=9) (5A’-F’). No labelling was observed in the SG epithelium of the control 
cultures, indicating low levels of apoptosis at this stage of development (Fig. 5A’,C’,E’), agreeing with 
the findings from Fig. 1G,J.  A few positive cells were evident in the mesenchyme, increasing with 
higher concentration of DMSO, indicating some cell death in the mesenchyme at the end of the culture 
period. This again highlights the toxicity of DMSO for developing SGs and the need to be careful when 
analysing results when using higher concentrations.  In the inhibitor treated cultures large numbers of 
positive cells were concentrated at the centre of the main ducts, corresponding to the pattern of 
apoptosis observed in glands in vitro at the start of culture (Fig. 5B’,D’,F’ compared to Fig 1). In 
addition to the effect on width of the duct, lumen formation also appeared abnormal. In the controls at 
100µM and 150µM clear, wide, cell free lumens formed in the central stalk (Fig. 5A,A’,B,B’). In 
contrast, this region in the caspase inhibitor cultures was filled with FITC labelled cells (Fig. 5D). In 
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section the lack of lumen was clear in the inhibitor treated cultures (Suppl. Fig. 1). In addition to defects 
in duct morphogenesis E13.5 samples also showed a dose dependent defect in branching morphogenesis 
(Fig. 5). The reduced branching was not expected as very few apoptotic cells were associated with this 
part of the gland at these stages, however the FITC marker also showed high levels of inhibitor binding 
in the mesenchyme, particularly at high concentrations (Fig. 5D’, F’) suggesting that the inhibitor may 
also have impacted on normal development of the mesenchyme, therefore indirectly affecting branching 
morphogenesis.  
 
Discussion  
Apoptosis has been recognized as one of the most important mechanisms involved in 
developmental dynamics (Flusberg and Sorger 2015) with the large caspases family being key 
regulators of the main programmed cell death pathways (Degterev et al. 2003; Kuranaga 2011; 
Hengartner 2000; Taylor et al. 2008). Branching morphogenesis regulates the formation of distinct 
organs like lungs, kidney, mammary and salivary glands, which can perform essential physiological 
functions, such as exchanging gases or production of secretions (Ochoa-Espinosa and Affolter 2012; 
Patel et al. 2006; Patel and Hoffman 2014; Larsen et al. 2010). Studies on epithelial tube morphogenesis 
have highlighted the involvement of distinct methods for lumen formation depending on the type of 
organ involved (Andrew and Ewald 2010; Chung and Andrew 2008; Lubarsky and Krasnow 2003). In 
SGs, it has been suggested that the central cells of the epithelial stalks undergo apoptosis in a process 
known as cavitation, clearing the luminal space during embryonic SG development (Wells and Patel 
2010; Tucker 2007). Corroborating with these previous reports, our findings illustrate the presence of 
dying cells in the centre of the presumptive ducts as shown by Lysotracker staining, activated caspase-3 
and TUNEL. Temporal expression of apoptotic cells in duct formation however diverged from previous 
studies. To date, it has been reported that mouse SG lumen spaces start opening only from stages E14.5 
or E15.5, with apoptotic cells and cleaved caspase-3 observed from E14.5 (Jaskoll and Melnick 1999; 
Melnick et al. 2001). It is therefore assumed that SGs are comprised of solid and non-luminised cords 
before this time point (Jaskoll et al. 2001; Larsen et al. 2006; Tucker 2007). In this study, apoptotic cells 
were detected at earlier stages, from E12.5, suggesting an important early role for apoptosis in the 
formation of the lumen of the central SG ducts, and the central duct was shown to open at early stages 
of development before the rest of the gland had undergone branching morphogenesis. This finding was 
further supported by the expression of K7 in the centre of the main stalk of developing SGs from E12.5 
(Walker et al. 2008). Such discrepancy could be due to the fact that earlier stages were not studied in 
details or that different methods for detecting apoptosis were employed. Melnick and Jaskoll reported 
the presence of apoptotic cells only from E14.5 using the Apostain assay, which identifies DNA after 
8	  
	  
caspase cleavage and before DNA fragmentation (Jaskoll and Melnick 1999). Comparison between 
TUNEL and Apostain assays have reported good reliability of both techniques although their outcomes 
showed slightly variations in the timing and amount of expression (Prochazkova et al. 2003). Our 
results revealed scarce/occasional apoptotic cells (cleaved caspase-3 and TUNEL positives) at later 
stages E14.5 and E15.5, and no overt defect in gland development in cultures treated with inhibitor 
from E14.5, indicating a more minor role for apoptosis at these later time points.  
Functional experiments were performed to assess the effects of suppressing apoptotic activity in 
SG development through in vitro pan-caspase inhibition. The Z-VAD-FMK inhibitor binds irreversibly 
to active caspases, and from the lowest concentration of 100µM it was able to compromise SG 
development at early stages. In previous studies in epithelial cell cultures, apoptotic inhibition was 
sufficient to avoid lumen formation when cell polarisation was not enhanced (Martín-Belmonte et al. 
2008). However when cell polarisation was stimulated in prostate epithelial models, inhibition of 
apoptosis only delayed lumen formation (Pearson et al. 2009). Studies with mammary cell cultures have 
also shown similar results by inhibiting apoptosis, correlating apoptosis with generation and 
maintenance of hollow lumen spaces (Debnath et al. 2002). 
Defects in branching and duct formation due to pan-caspase inhibition revealed an important 
function of apoptosis during SG development. However it is worth bearing in mind that caspase 
inhibition can trigger the activation of non-caspase dependent cell death pathways, such as necrosis and 
autophagy, which could compensate for the absence of apoptosis (Vandenabeele et al. 2006). 
Additionally, it has been reported that caspase functions are not exclusively apoptotic, being also 
correlated to dynamic cell processes such as cell-fate determination, compensatory proliferation of 
neighboring cells, and actin cytoskeleton reorganization, in a non-apoptotic context during mouse 
development (Kuranaga 2011; Wang and Lenardo 2000). Caspase inhibition can therefore potentially 
affect other essential mechanisms during embryogenesis, which might have resulted in the severe 
phenotypes observed in our in vitro cultures not only in duct formation but also in epithelial branching. 
The importance of apoptosis during organ development has recently been correlated to effects on 
proliferation, movement and shape of neighbouring cells (Pérezz-Garijo and Steller 2015), suggesting 
an additional function for those apoptotic cells during early SG development.  
Studies analysing epithelial cell interactions during SG development have shown links between 
control of lumen formation and cell polarisation (Cutler and Mooradian 1987; Andrew and Ewald 
2010), supported more recently by genetic links between the two processes (Nedvetsky et al. 2014). 
Neuronal-derived vasoactive intestinal peptide (VIP) was found as an important regulator of key steps 
during epithelial tubulogenesis in SG development, where exogenous VIP stimulated the formation of a 
single contiguous lumen space, as marked by apical aPKC and subapical GM130, from E13. Moreover 
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it was reported that VIP-induced lumen formation did not require apoptosis, showing normal lumen 
formation in SGs cultured with pan-caspase inhibitor. In this experiment the inhibitor was used at 
50µM, whereas we saw only partial inhibition using a higher concentration of 100µM, the lack of 
phenotype in the Nedvetsky paper could therefore be due to the low dose of Z-VAD-FMK used. 
Normal lumens were also observed in Bax knockout mice, however they were only analysed at E17. In 
this case, it is possible that Bax-dependent lumen formation was compensated for by other cell death 
mechanisms or analogous molecules. This protein is only required for intrinsic apoptosis and it shares 
similar pro-apoptotic function with another apoptotic protein Bak (Karbowski et al. 2006; Lindsten et 
al. 2000). Compensation by other cell death pathways is a common mechanism observed in other areas 
where cell death has been investigated, for example in the limb (Miura 2012; Suzanne and Steller 
2013). 
Another cell mechanism named anoikis has also been indicated as an important process during 
epithelial tube formation, as seen in mammary gland morphogenesis (Debnath et al. 2002; Mailleux et 
al. 2007). This is based on the loss of cell anchorage, which disturbs cell-cell and cell-extracellular 
matrix adhesion interactions, playing important role in the physiological induction of apoptosis during 
development and pathogenesis, mainly regarding metastatic transformation (Grossmann 2002). 
Corroborating with this hypothesis, in our SG explant cultures the apoptotic inhibition marker FITC-Z-
VAD-FMK indicated the presence of many unorganised cells remaining in the centre of the 
presumptive duct, not showing a clear lumen space and being detached from the polarised epithelial 
cells lining the cavity. Given that anoikis is also potentially responsible for triggering apoptosis during 
lumen space opening, cavitation could actually represent a special case of cord hollowing, which 
requires cell polarization and the extra step of clearing the lumen (Andrew and Ewald 2010).  
In conclusion, initial lumen formation in the SG main stalk seems to occur by an apoptosis 
driven mechanism. The decreasing expression of apoptotic cells through SG development either in 
ducts or acini suggests that further lumen formation and maintenance of the subsequent ducts possibly 
use other mechanisms. Cell polarisation, anoikis and non-apoptotic cell death pathways may be 
essential to these developmental processes. It will therefore be important to further explore these ideas 
in order to establish a definite causal relationship between lumen formation, lumen maintenance and 
cell death.  
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Figure legends 
Figure 1: Cell death in early SG development 
(A, B, C, D) E12.5. (E, F, G, H) E13.5. (I, J, K, L) E14.5. (M, N, O, P) Main duct of submandibular 
gland. (Q, R, S) E13.5 SG. 
(A, E, I) Histology sagittal sections of E12.5 to E14.5 SG (B, F, J) E-cadherin expression in developing 
SG epithelium. (C, G, K, S) Activated caspase-3. (D, H, L) TUNEL. (M, O) DAPI staining with 
characteristic apoptotic condensed nuclei visible in the central lumen area (arrowheads). (N, P, R) 
Lysotracker pseudocoloured green from red. At E12.5 the first signs of apoptosis are visible as shown 
by all three markers (C, D, N, arrows), with higher number at E13.5 as the gland starts to branch (G, H, 
P, arrows). At E14.5 scarce or no positive cells are present in the lumen spaces within the ducts (K, L). 
Arrows indicate positive cells, arrowheads indicate forming lumens. OE = Oral epithelium. (Q, R, S, T) 
Comparison between Lysotracker and cleaved caspase-3 expression (Q, R, arrows) localisation in the 
same E13.5 SG sample. Cleaved Caspase-3 positive cells are present mainly within the duct of the 
sublingual gland, located to the left of the larger submandibular gland. Lysotracker is mainly visualised 
in submandibular ductal cells. High magnification of the main forming duct in the submandibular gland 
showing both Lysotracker and cleaved caspase-3 expression is shown in T. Scale bar = 100µm. 
 
Figure 2: Presumptive lumen formation as labelled by Cytokeratin (K) 7 
(A) K7 positive cells are localised at the centre of the initial solid stalk at E12.5 (arrows). (B) K7 
remains expressed at E13.5 restricted to the presumptive luminal area (arrow). (C) At E14.5 K7 is more 
evident within the lumen space of SG ducts. (D) K7 is also expressed in the oral epithelium. Asterix 
marks submandibular gland. Scale bar = 100µm. 
 
Figure 3: Early inhibition of caspases leads to defects in duct morphology 
(A) E12.5 SG explants cultured for 72h. A defect in duct morphology is evident between the control 
(DMSO) and the experimental (ZVAD) group after 48h and 72h of culture. Arrows indicate the ducts at 
72hrs. Scale bar = 500µm.  
(B) Paired student t-test statistical analysis of the duct diameter of both groups in E12.5 SG cultures. No 
difference in duct dimensions was observed prior to culture at 0h, compared to statistically significantly 
narrowing of the ducts in control cultures compared to treated cultures after 24, 48 and 72 hours.  
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N=18 for E12.5 and N=9 for E13.5 and E14.5 glands. *p = 0.02; **p = 0.008; ***p = 0.0006. Error bars 
represent one standard error of the mean. 
 
Figure 4: Loss of activated caspase-3 leads to a reduction in duct narrowing and branching at the 
pseudoglandular stage 
(A) Expression of cleaved caspase-3 within developing submandibular ducts of treated and non-treated 
E13.5 SG cultures after 20h (arrows). High levels of cleaved caspase-3 (red) positive cells were found 
within developing lumen space of all controls (left hand side column). From 150µM of Z-VAD-FMK, 
cleaved caspase-3 was completely absent, with a few labelled cells present at 100µM (right hand 
column). Scale bar = 100µm. 
(B) Unpaired t-test comparing the mean duct diameter increase (Day3-Day 0) of E13.5 SGs cultured for 
72h for the three different Z-VAD-FMK concentrations. N = 9, *p = 0.05. 
(C) Paired student t-test statistical analysis of the final duct diameter of both groups in E13.5 SG 
cultures. No difference in duct dimensions were observed prior to culture at 0h, compared to 
statistically significantly narrowing of the ducts in control cultures compared to treated cultures after 
24, 48 and 72 hours. N = 18, *p = 0.03. 
(D) Mean Spooner ratio for treated (Z-VAD-FMK) and non-treated groups (DMSO) after 48h. Paired 
student t-test show a significant decrease in branching using 150 and 200µM of inhibitor. N = 9, *p = 
0.01, **p = 0.006.  
 
Figure 5: Inhibition of caspases at E13.5 leads to loss of lumen formation in the main stalk 
(A-F) Explants cultured from E13.5 for 72hours, with or without Z-VAD-FMK inhibitor. FITC-Z-
VAD-FMK added to all cultures prior to fixation to label cells that are currently undergoing apoptosis 
(control and treated group, A’-F’), and caspase positive cells that have previously been inhibited from 
undergoing apoptosis (treated group). 
(A, C, E) Morphological images of control explants (DMSO treated). Arrowheads indicate areas of 
branching morphogenesis. (A’, C’, E’) Confocal images of the same control group highlighting absence 
of apoptotic inhibition inside the main ducts (arrows) when treated with FITC-Z-VAD-FMK before 
fixation. (E) Some apoptosis (green label) is evident in the mesenchyme at high levels of DMSO. (B, D, 
F) Pan-caspase inhibition at a range of concentrations, demonstrating defects in branching 
morphogenesis (arrowheads) and expansion of the duct diameter (arrows) in the absence of caspases. 
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(B’, D’, F’) Confocal images of the same treated group highlighting presence of apoptotic inhibition 
(green labelled cells) inside the main ducts (arrows). The main ducts are filled with cells rather than 
cell-free lumen, as seen in controls. High levels of apoptosis (green label) are observed in the 
mesenchyme. Scale bar = 500µm. 
 
Supplementary Figure 1: Apoptosis in early salivary gland development and its role in lumen 
formation 
(A) TUNEL positive cells in the forming luminal area at E12.5 (arrow). (B) E13.5 SG sections with 
TUNEL positive cells in the ductal region (arrow). (C,D) Histological sections of E13.5 explants after 3 
days of culture in DMSO (C – control group) and in pan-caspase inhibitor Z-VAD-FMK (D). Arrows 
exhibit the presence of well-formed luminal spaces in C, while wide non-luminised stalks are observed 
in the absence of caspase activation (D). 
 
Supplementary Figure 2: Apoptotic inhibition at E14.5 does not affect branching and lumen 
formation 
(A-F) Explant cultures of E14.5 SG after 48h of treatment with and without Z-VAD-FMK at 
different concentrations. (A’- F’) Respective morphology of the explants with DAPI staining. 
Lumen space is formed normally at all concentrations of inhibitor at this stage of development 
(B’, D’, F’, arrows). Scale bar = 500µm. 
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